Histone Deacetylase Inhibitors Inhibit Lung Adenocarcinoma Metastasis via HDAC2/YY1 Mediated Downregulation of Cdh1

Scientists employed a range of techniques, including qPCR, immunoblotting, co-immunoprecipitation, chromatin-immunoprecipitation, and cell migration assays, in conjunction with online database analysis, to investigate the role of histone deacetylase inhibitors and histone deacetylase 2 (HDAC2)/YY1 in the process of lung adenocarcinoma migration.